MYC expression has been seen previously to regulate the immune TME in other malignancies, including hematologic malignancies, liver cancer, non-small cell lung cancer, and neuroblastoma, among others, through modulation of both immune effector cells and immune regulatory cytokines27–31. This evidence concerns the gene MYC and neuroblastoma.